ArticleAmerican journal of preventive cardiology2026
Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center.
Eleonora Avenatti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.